Obstetric Outcomes in Women with Rheumatic Disease and COVID-19 in the Context of Vaccination Status.
Sinead MaguireSamar Al-EmadiPaula AlbaMathia Cecilia AguiarTalal Al LawatiGelsomina AlleBonnie BermasSuleman BhanaAnic BranimirInita BulinaMegan ClowseKarina CogoIris ColungaClaire CookKaren J CortezKathryn DaoMilena GianfrancescoMonique Gore-MasseyLaure GossecRebecca GraingerJonathon HausmanTiffany Y T HsuKimme HyrichCarolina IsnardiYumeko KawanoRachael KildingDaria A KusevichSaskia Lawson-ToveyJean LiewEoghan McCarthyAnna MontgumerySebastian MoyanoNoreen NasirIvan PadjenCharalampos PapagorasNaomi J PatelMariana PeraCecilia PisoniGuillermo Pons-EstelAntonio L QuiambaoRosana QuintanaEric RudermanSebastian SattuiVeronica SavioSavino SciasciaMarieta SencarovaRosa Serrano MoralesFaizah SiddiqueEmily SirotichJeffrey SparksAnja StrangfeldPaul SufkaHelen TannerYohana TisseraZachary WallaceMarina L WernerLeanna WiseAngus B WorthingJoAnn ZellJulija ZepaPedro M MachadoJinoos YazdanyPhilip RobinsonRichard Conwaynull nullPublished in: Rheumatology (Oxford, England) (2022)
In this descriptive study, unvaccinated pregnant women with RMD and COVID-19 had a greater number of PTB compared with those fully vaccinated against COVID-19. Additionally, the need for COVID-19 pharmacological treatment was uncommon in pregnant women with RMD regardless of vaccination status. These results support active promotion of COVID-19 vaccination in women with RMD who are pregnant or planning a pregnancy.